[Antibiotic therapy of open pulmonary tuberculosis; results 4 to 24 months after termination of streptomycin-PAS-isoniazid therapy in 153 cases].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents; D007536:Isomerism; D007538:Isoniazid; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D007538:Isoniazid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
TBC polmonare aperta trattata con sola terapia antibatterica; studio dei risultati a 4-24 mesi dalla fine del trattamento con streptomicina-PAS-isoniazide, in 153 casi.